Notice of meeting - 2026 Combined General Shareholder's Meeting

TABLE OF DELEGATIONS OF AUTHORITY AND AUTHORIZATIONS GRANTED TO THE BOARD OF DIRECTORS REGARDING FINANCIAL MATTERS
Type of delegation or authorization	Date of the meeting	Term of delegation/expiry	Amount authorized	Used in 2025
EQUITY ISSUES
Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17^th and 18^th resolutions of the General Shareholders’ Meeting of May 29, 2024^*	Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17 ^th and 18 ^th resolutions of the General Shareholders’ Meeting of May 29, 2024^* Date of the meeting May 29, 2024 (20^th resolution)	Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17 ^th and 18 ^th resolutions of the General Shareholders’ Meeting of May 29, 2024^* Term of delegation/expiry 26 months/ July 29, 2026^***	Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17 ^th and 18 ^th resolutions of the General Shareholders’ Meeting of May 29, 2024^* Amount authorized No more than 10% of the share capital per year ⁽¹⁾⁽³⁾	Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17 ^th and 18 ^th resolutions of the General Shareholders’ Meeting of May 29, 2024^* Used in 2025 None
Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums^*	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Date of the meeting May 29, 2024 (21^st resolution)	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Term of delegation/expiry 26 months/ July 29, 2026^**	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Amount authorized Maximum nominal amount: €30,000,000 ⁽¹⁾	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Used in 2025 None
Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company^*	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Date of the meeting May 29, 2024 (22^nd resolution)	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Term of delegation/expiry 26 months/ July 29, 2026^**	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Amount authorized Maximum nominal amount: €9,000,000 ⁽¹⁾⁽³⁾ (3) Maximum nominal amount of debt securities: None €1,200,000,000 ⁽²⁾	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Used in 2025 None
Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer^*	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Date of the meeting May 29, 2024 (23^rd resolution)	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Term of delegation/expiry 26 months/ July 29, 2026^**	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Amount authorized Maximum nominal amount: €9,000,000 ⁽¹⁾⁽³⁾ Maximum nominal amount of debt securities: €1,200,000,000 ⁽²⁾	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Used in 2025 None
ISSUES RESERVED FOR COMPANY OR GROUPE EMPLOYEES AND MANAGERS
Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Date of the meeting May 29, 2024 (24^th resolution)	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Term of delegation/expiry 38 months/ July 29, 2027	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Amount authorized No more than 3% of the share capital (including 0.3% of the share capital for executive corporate officers)	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Used in 2025 Grant of 782,767 existing shares
Authorization to grant stock options to employees and/or corporate officers of the Company and the Group companies	Authorization to grant stock options to employees and/or corporate officers of the Company and the Group companies Date of the meeting May 27, 2025 (19^th resolution)	Authorization to grant stock options to employees and/or corporate officers of the Company and the Group companies Term of delegation/expiry 38 months/ July 27, 2028	Authorization to grant stock options to employees and/or corporate officers of the Company and the Group companies Amount authorized No more than 3% of the share capital (including 0.3% of the share capital for executive corporate officers)	Authorization to grant stock options to employees and/or corporate officers of the Company and the Group companies Used in 2025 None
Delegation to increase capital for the benefit of subscribers to a Company savings plan	Delegation to increase capital for the benefit of subscribers to a Company savings plan Date of the meeting May 27, 2025 (20^th resolution)	Delegation to increase capital for the benefit of subscribers to a Company savings plan Term of delegation/expiry 26 months/ July 27, 2027^**	Delegation to increase capital for the benefit of subscribers to a Company savings plan Amount authorized Maximum nominal amount: €2,800,000 ⁽¹⁾⁽⁵⁾	Delegation to increase capital for the benefit of subscribers to a Company savings plan Used in 2025 None
Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Date of the meeting May 27, 2025 (21^st resolution)	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Term of delegation/expiry 18 months/ November 27, 2026^**	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Amount authorized Maximum nominal amount: €2,800,000 ⁽¹⁾⁽⁵⁾	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Used in 2025 None

This amount counts toward the €30,000,000 overall ceiling for all capital increases set forth by the General Shareholders’ Meeting of May 29, 2024 in its 16th resolution.
This amount counts toward the €1,200,000,000 overall ceiling for all debt security issues set by the General Shareholders’ Meeting of May 29, 2024 in its 16th resolution.
This amount counts towards the €9,000,000 overall ceiling for capital increases without preferential subscription rights set forth by the General Shareholders’ Meeting of May 29, 2024 in its 17th resolution.
These ceilings count towards the 3% and the 0.3% ceilings set forth by the General Shareholders’ Meeting of May 29, 2024 in its 24th resolution.
This ceiling applies to all possible capital increases under the 20th and 21st resolutions of the General Shareholders’ Meeting of May 27, 2025.

* Unless there is prior authorization by the General Shareholders’ Meeting, the Board of Directors cannot use this authorization or delegation from the time a third party has filed a public offer for Company shares up to the end of the offer period.
** This delegation or authorization is set to expire, for the unused portion and the remaining time period, upon adoption of a resolution pertaining to a new authorization or delegation with a similar purpose by the General Shareholders’ Meeting of May 27, 2026.
*** This delegation has become obsolete due to the changes introduced by the (French) Attractiveness Law of June 13, 2024 and will expire at the end of the General Shareholders’ Meeting of May 27, 2026.

Notice of meeting - 2026 Combined General Shareholder's Meeting

What you need to know